News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Erinn P. Downs

Articles by Erinn P. Downs

48 Prevalence of “HER2 Ultra-Low” Among Advanced Breast Cancer Patients With Historical IHC0 Status

ByAnushree Iyengar,Sandhya Mehta,Hannah Barman,Nivedita Rangarajan,Sue-Ann Woo,Simone T. Sredni,Rosemarie Di Donato,Safak Simsek,Erinn P. Downs,Aziza Nassar,Darren M. Wilson,Katherine Krieser,Elise Bieri Patzke,Natalie Kyek,Jason Hipp,Tyler Wagner, PhD

May 25th 2025

Latest Updated Articles

Trending on CancerNetwork

Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC

Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC

Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology

Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups

Lenvatinib/Everolimus Beats Cabozantinib in Phase 2 RCC Study

© 2025 MJH Life Sciences^®

All rights reserved.